GB0015324D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB0015324D0
GB0015324D0 GBGB0015324.7A GB0015324A GB0015324D0 GB 0015324 D0 GB0015324 D0 GB 0015324D0 GB 0015324 A GB0015324 A GB 0015324A GB 0015324 D0 GB0015324 D0 GB 0015324D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0015324.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Priority to GBGB0015324.7A priority Critical patent/GB0015324D0/en
Publication of GB0015324D0 publication Critical patent/GB0015324D0/en
Priority to PCT/AU2001/000748 priority patent/WO2001097804A1/en
Priority to AU2001272718A priority patent/AU2001272718A1/en
Priority to PCT/IB2001/001402 priority patent/WO2001097792A2/en
Priority to AU2001267135A priority patent/AU2001267135A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0015324.7A 2000-06-22 2000-06-22 Medicaments Ceased GB0015324D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0015324.7A GB0015324D0 (en) 2000-06-22 2000-06-22 Medicaments
PCT/AU2001/000748 WO2001097804A1 (en) 2000-06-22 2001-06-22 Medicaments
AU2001272718A AU2001272718A1 (en) 2000-06-22 2001-06-22 Medicaments
PCT/IB2001/001402 WO2001097792A2 (en) 2000-06-22 2001-06-22 Neuraminidase inhibitors in the treatment of equine influenza virus infection
AU2001267135A AU2001267135A1 (en) 2000-06-22 2001-06-22 Medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0015324.7A GB0015324D0 (en) 2000-06-22 2000-06-22 Medicaments

Publications (1)

Publication Number Publication Date
GB0015324D0 true GB0015324D0 (en) 2000-08-16

Family

ID=9894198

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0015324.7A Ceased GB0015324D0 (en) 2000-06-22 2000-06-22 Medicaments

Country Status (3)

Country Link
AU (2) AU2001272718A1 (en)
GB (1) GB0015324D0 (en)
WO (2) WO2001097792A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US20070203241A1 (en) 2006-02-13 2007-08-30 Babu Yarlagadda S Antiviral treatments
KR20230003248A (en) * 2006-02-13 2023-01-05 바이오크리스트 파마수티컬즈, 인코퍼레이티드 Intravenous antiviral treatments
EA200870430A1 (en) * 2006-04-12 2009-06-30 Байокрист Фармасьютикалз, Инк. INTRAMUSCULAR ANTIVIRUS METHODS OF TREATMENT
CN102584637B (en) * 2011-01-17 2014-07-09 天津药物研究院 Peramivir hydrate crystal, preparation method, medical compound and usage thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282950B6 (en) * 1990-04-24 2003-01-09 Biota Scientific Management Pty Ltd Alpha-D-neuraminic acid derivatives, their preparation method, use and pharmaceutical preparations based on them
AU720933B2 (en) * 1995-02-27 2000-06-15 Gilead Sciences, Inc. Novel selective inhibitors of viral or bacterial neuraminidases
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
CN1238783A (en) * 1996-11-14 1999-12-15 百奥塔科学管理有限公司 Method and novel compounds for use therein
ES2324746T3 (en) * 1997-12-17 2009-08-13 Biocryst Pharmaceuticals Inc. CYCLOPENTANE AND CYCLOPENTENE COMPOUNDS REPLACED USEFUL AS INHIBITORS OF NEURAMINIDASA.
WO2001029021A1 (en) * 1999-10-19 2001-04-26 Abbott Laboratories Neuraminidase inhibitors

Also Published As

Publication number Publication date
AU2001272718A1 (en) 2002-01-02
WO2001097804A1 (en) 2001-12-27
WO2001097792A2 (en) 2001-12-27
AU2001267135A1 (en) 2002-01-02
WO2001097792A3 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
AU2002365120A8 (en) Medicaments
GB0009605D0 (en) Medicaments
GB0020691D0 (en) Pharmaceutical combination
GB0002312D0 (en) Medicaments
GB0012291D0 (en) Pharmaceutical combination
GB0102902D0 (en) Medicaments
GB0024362D0 (en) Medicaments
GB0015324D0 (en) Medicaments
GB0021487D0 (en) Pharmaceutical
GB0012293D0 (en) Pharmaceutical combination
HU0000918D0 (en) Medicaments
GB0022155D0 (en) Medicaments
GB0023922D0 (en) Medicaments
GB0031083D0 (en) Medicaments
GB0009046D0 (en) Medicaments
GB0015851D0 (en) Medicaments
GB0016133D0 (en) Medicaments
GB0016134D0 (en) Medicaments
GB0022156D0 (en) Medicaments
GB0115182D0 (en) Medicaments
GB0017076D0 (en) Medicament
GB0017092D0 (en) Medicament
GB0004020D0 (en) Pharmaceutical
GB0017141D0 (en) Pharmaceutical
GB0016563D0 (en) Pharmaceutical

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)